The First Reported Clinical Outcomes of a Next Generation Five-Layer Foam Dressing for Exudate Management: A Retrospective, Real World, Cohort Analysis From the United States.

The management of wound exudate is a critical component of best practice, evidence-based wound care. This analysis aimed to demonstrate the first clinical and performance outcomes of a newly designed, next generation five-layer foam dressing for exudate management. A real-world, retrospective cohort analysis was conducted at two healthcare organizations in the United States (US). Patients with acute or chronic wounds receiving a next generation five-layer foam dressing were extracted from the organizations' Electronic Medical Record (EMR) systems. Utilizing descriptive statistics, the clinical outcomes and Healthcare Professional (HCP) reported dressing performance outcomes are reported. Twenty-five patients with 28 acute or chronic wounds were evaluated during routine care, over a median treatment period of 42 days. Exudate levels improved, with high exudate decreasing from 60.7% to 39.3%, and favourable shifts in exudate type over time. Periwound condition improved, with maceration decreasing from 67.9% to 14.3%. Median wound area and volume decreased by 46.3% and 51.3%, respectively, with 17.9% of wounds achieving complete closure. HCP-reported dressing performance exceeded expectations at 93%. This retrospective analysis demonstrates improvements in exudate levels, periwound status and wound status, alongside favourable HCP-reported performance of a new next-generation five-layer foam dressing, during routine wound management.